Jeffrey H. Buchalter

Overview

Jeffrey H. Buchalter received an average of $4M in total compensation, including $660K in salary, at Enzon Pharmaceuticals from 2006 to 2010.

Source: SEC filings on April 8, 2011 and April 16, 2008.

Related executives

We found 12 more executives who work or worked at Enzon Pharmaceuticals.

Richard Feinstein

Enzon Pharmaceuticals

Chief Financial Officer

Andrew Rackear

Enzon Pharmaceuticals

Chief Executive Officer

George Hebard

Enzon Pharmaceuticals

Chief Operating Officer

Aby Buchbinder

Enzon Pharmaceuticals

Former Vice President, Clinical Development

Charles Conover

Enzon Pharmaceuticals

Former Senior Vice President of Research & Development, Program Management

Timothy Daly

Enzon Pharmaceuticals

Chief Accounting Officer

Ana Stancic

Enzon Pharmaceuticals

Chief Financial Officer

Ralph del Campo

Enzon Pharmaceuticals

Chief Operating Officer

You may also like